European Foundation
for the Improvement of
Living and Working Conditions

The tripartite EU agency providing knowledge to assist
in the development of better social, employment and
work-related policies

EU PolicyWatch

Database of national-level policy measures

Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.

Factsheet for measure FR-2020-47/1462 – measures in France

Authorisation for employers to organise collective screening of employees

Autorisation accordée aux employeurs pour organiser le dépistage collectif des salariés

Country France , applies nationwide
Time period Open ended, started on 17 November 2020
Context COVID-19
Type Legislations or other statutory regulations
Category Protection of workers, adaptation of workplace
– Occupational health and safety
Author Frédéric Turlan (IRshare) and Eurofound
Measure added 26 November 2020 (updated 16 January 2025)

Background information

An order of 16 November provides, by amending an order of 10 July 2020, that, exceptionally, an employer may organise collective screening operations, using rapid diagnostic nasopharyngeal antigenic orientation tests for the detection of SARS-Cov 2, within targeted populations, in the event of suspicion of a "cluster" or particularly active circulation of the virus, after declaration to the State representative in the department.

Content of measure

The order notes state that 'the evolution of the epidemic makes it necessary to increase the testing capacity on the national territory' and that 'it is advisable to extend the use of rapid antigenic diagnostic tests and to supervise their use'. Therefore, exceptionally, an employer may organise collective screening operations, using rapid diagnostic nasopharyngeal antigenic orientation tests for the detection of SARS-Cov 2, within targeted populations, in the event of suspicion of a "cluster" or particularly active circulation of the virus, after declaration to the State representative in the department.

The tests are carried out by a doctor, nurse or pharmacist who themselves give the results to the people tested. This possibility is provided for in the national protocol to ensure the health and safety of employees in companies in the face of the COVID-19 epidemic, since its update of 29 October 2020. In this context, the employer must finance all the screening actions and the results of the tests cannot be communicated to him.

Use of measure

No information available.

Target groups

Workers Businesses Citizens
Applies to all workers Applies to all businesses Does not apply to citizens

Actors and funding

Actors Funding
National government
Company / Companies
Companies
Employer

Social partners

Social partners' role in designing the measure and form of involvement:

Trade unions Employers' organisations
Role No involvement No involvement
Form Not applicable Not applicable

Social partners' role in the implementation, monitoring and assessment phase:

  • No involvement
  • Main level of involvement: N/A

Involvement

No involvement, this in a governmental decision.

Views and reactions

No information available.

Sources

  • 16 November 2020: Arrêté du 16 novembre 2020 modifiant l'arrêté du 10 juillet 2020 prescrivant les mesures d'organisation et de fonctionnement du système de santé nécessaires pour faire face à l'épidémie de covid-19 dans le cadre de l'état d'urgence sanitaire

Citation

Eurofound (2020), Authorisation for employers to organise collective screening of employees, measure FR-2020-47/1462 (measures in France), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/FR-2020-47_1462.html

Share

Eurofound publications based on EU PolicyWatch

All publications are available on the EU PolicyWatch landing page .

Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.